198HO02103 DUETTO

Print/PDF
Registration Name CERETTESE DUETTO TV TL TY CF
Registration Number HOITA001991000958
Primary NAAB Code 198HO02103
Secondary Code(s)
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 7/25/2016
aAa 234156
DMS -
GFI 10.5%
Genetic Codes * TL TV TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire VENDAIRY DUOMILIA TV TL TY CF
MGS VAL-BISSON DOORMAN-ET
Beta Casein A1A2
Kappa Casein BB
Beta Lactoglobulin AB
INDEXES
NM$ -324, 80% R CM$ -328
NM Percentile 10% FM$ -310
GTPI 2223 GM$ -345
PRODUCTION TRAITS
290 Dtrs 167 herds 0 % US 88% R
Milk -4 Fat, % -37 , -0.14%
SCS 2.83, 87% R Protein, % -6 , -0.02%
Feed Saved -262 , 53% R Milking Speed 6.67 , 62% R
Health & Fertility
Productive Life -0.3      84% R Mastitis 0.7      74% R
Heifer Livability 0.2       53% R Metritis -0.9      69% R
Livability -1.7      79% R D. Abom -0.2      71% R
DPR -0.2      85% R Ketosis 0.0      69% R
HCR 0.5      78% R R. Placenta 0.2      70% R
FSC -3.2      75% R Milk Fever -0.1      62% R
CCR -0.3      85% R
SCR -        -
DIA -0.2      40% R
RSP 0.2      47% R
Calving Traits
Sire CE 1.4      36% R 226 Obs
Daughter CE 1.8      26% R 0 Obs, 201 Dtrs
Sire SB 4.8      29% R 573 Obs
Daughter SB 4.0      37% R 0 Obs, Dtrs
Gestation Length 1.0      74% R 0 Obs, 0 Dtrs
Early First Calving -2.0      74% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
213 Dtrs 126 herds 71% R
PTA Type -0.22 UDC -0.44
HCC -0.46 BWC 0.63
FLC -0.10
Linear Traits
Stature 0.40
Tall
Strength -0.02
Strong
Body Depth -0.19
Shallow
Dairy Form -1.25
Closed
Rump Angle 1.14
Sloped
Thurl Width -0.13
Narrow
Rear Legs-Side View 0.23
Curved
Rear Legs-Rear View 0.27
Straight
Foot Angle -0.47
Low
Feet & Legs Score -0.05
Low
F.U. Attachment -0.29
Weak
Rear Udder Height -1.13
Low
Rear Udder Width -1.03
Narrow
Udder Cleft 0.01
Strong
Udder Depth 0.75
Shallow
Front Teat Placement 1.07
Close
Rear Teat Placement 1.57
Close
Teat Length -0.61
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO